EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Thymoquinone Ameliorates Carfilzomib-Induced Renal Impairment by Modulating Oxidative Stress Markers, Inflammatory/Apoptotic Mediators, and Augmenting Nrf2 in Rats

Marwa M Qadri iD, Mohammad Firoz Alam iD, Zenat A Khired, Reem O Alaqi, Amani A Khardali, Moudi M Alasmari, Ahmad S S Alrashah, Hisham M A Muzafar, Abdullah M Qahl

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms241310621 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Marwa M Qadri und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Toxicology, College of Pharmacy, Jazan University, Jazan 45142, Saudi Arabia. Hauptthemen laut MEDLINE: Antioxidants, Renal Insufficiency. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deanship of Scientific Research, Jazan University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chemotherapy-induced kidney damage is an emerging problem that restricts cancer treatment effectiveness. The proteasome inhibitor carfilzomib (CFZ) is primarily used to treat multiple myeloma and has been associated with severe renal injury in humans. CFZ-induced nephrotoxicity remains an unmet medical need, and there is an urgent need to find and develop a nephroprotective and antioxidant therapy for this condition. Thymoquinone (TQ) is a bioactive compound that has been isolated from Nigella sativa seeds. It has a wide range of pharmacological properties. Therefore, this experimental design aimed to study the effectiveness of TQ against CFZ-induced renal toxicity in rats. The first group of rats was a normal control (CNT); the second group received CFZ (4 mg/kg b.w.); the third and fourth groups received TQ (10 and 20 mg/kg b.w.) 2 h before receiving CFZ; the fifth group received only TQ (20 mg/kg b.w.). This experiment was conducted for 16 days, and at the end of the experiment, blood samples and kidney tissue were collected for biochemical assays. The results indicated that administration of CFZ significantly enhanced serum marker levels such as BUN, creatinine, and uric acid in the CFZ group. Similarly, it was also noticed that CFZ administration induced oxidative stress by reducing antioxidants (GSH) and antioxidant enzymes (CAT and SOD) and increasing lipid peroxidation. CFZ treatment also enhanced the expression of IL-1β, IL-6, and TNF-α production. Moreover, CFZ increased caspase-3 concentrations and reduced Nrf2 expression in the CFZ-administered group. However, treatment with 10 and 20 mg/kg TQ significantly decreased serum markers and increased antioxidant enzymes. TQ treatment considerably reduced IL-1β, IL-6, TNF-α, and caspase-3 concentrations. Overall, this biochemical estimation was also supported by histopathological outcomes. This study revealed that TQ administration significantly mitigated the negative effects of CFZ treatment on Nrf2 expression. Thus, it indicates that TQ may have utility as a potential drug to prevent CFZ-induced nephrotoxicity in the future.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AntioxidantsRenal InsufficiencyHumansRatsAnimalsCaspase 3NF-E2-Related Factor 2Rats, WistarInflammation MediatorsTumor Necrosis Factor-alphaInterleukin-6KidneyOxidative StressBenzoquinonesOligopeptides

Stichwörter der Autor:innen

anti-inflammatoryantioxidantcarfilzomibgene expressionnephroprotectivenephrotoxicitythymoquinone

Substanzen

AntioxidantsCaspase 3NF-E2-Related Factor 2Inflammation MediatorsTumor Necrosis Factor-alphaInterleukin-6BenzoquinonescarfilzomibOligopeptidesthymoquinone

Autor:innen und Institutionen

  • Department of Pharmacology and Toxicology, College of Pharmacy, Jazan University, Jazan 45142, Saudi Arabia.
  • Inflammation Pharmacology and Drug Discovery Unit, Medical Research Center (MRC), Jazan University, Jazan 45142, Saudi Arabia.
  • Surgical Department, Faculty of Medicine, Jazan University, Jazan 45142, Saudi Arabia.
  • Department of Clinical Pharmacy, College of Pharmacy, Jazan University, Jazan 45142, Saudi Arabia.
  • College of Medicine, King Saud Bin Abdulaziz University for Health Sciences, Jeddah 22384, Saudi Arabia.
  • King Abdullah International Medical Research Center (KAIMRC), Jeddah 22384, Saudi Arabia.

ORCID-Profile: Marwa M Qadri, Mohammad Firoz Alam

Förderung

  • Deanship of Scientific Research, Jazan University

Zitieren

APA

Qadri, M. M., Alam, M. F., Khired, Z. A., Alaqi, R. O., Khardali, A. A., Alasmari, M. M., Alrashah, A. S. S., Muzafar, H. M. A., & Qahl, A. M. (2023). Thymoquinone Ameliorates Carfilzomib-Induced Renal Impairment by Modulating Oxidative Stress Markers, Inflammatory/Apoptotic Mediators, and Augmenting Nrf2 in Rats. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms241310621

Vancouver

Qadri MM, Alam MF, Khired ZA, Alaqi RO, Khardali AA, Alasmari MM, et al. Thymoquinone Ameliorates Carfilzomib-Induced Renal Impairment by Modulating Oxidative Stress Markers, Inflammatory/Apoptotic Mediators, and Augmenting Nrf2 in Rats. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms241310621

BibTeX
@article{Qadri2023,
  author = {Qadri, Marwa M and Alam, Mohammad Firoz and Khired, Zenat A and Alaqi, Reem O and Khardali, Amani A and Alasmari, Moudi M and Alrashah, Ahmad S S and Muzafar, Hisham M A and Qahl, Abdullah M},
  title = {Thymoquinone Ameliorates Carfilzomib-Induced Renal Impairment by Modulating Oxidative Stress Markers, Inflammatory/Apoptotic Mediators, and Augmenting Nrf2 in Rats},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms241310621}
}
Kostenlos starten →